Genomic Edition of
Ashbya gossypii
Biotechnology
CRISPR/Cas9
Gene editing
Genome engineering
One-vector
Journal
Bio-protocol
ISSN: 2331-8325
Titre abrégé: Bio Protoc
Pays: United States
ID NLM: 101635102
Informations de publication
Date de publication:
20 Jun 2020
20 Jun 2020
Historique:
received:
27
01
2020
revised:
25
03
2020
accepted:
30
03
2020
entrez:
4
3
2021
pubmed:
5
3
2021
medline:
5
3
2021
Statut:
epublish
Résumé
The CRISPR/Cas9 system is a novel genetic tool which allows the precise manipulation of virtually any genomic sequence. In this protocol, we use a specific CRISPR/Cas9 system for the manipulation of
Identifiants
pubmed: 33659330
doi: 10.21769/BioProtoc.3660
pii: e3660
pmc: PMC7842619
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e3660Informations de copyright
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare no financial or commercial conflict of interest.
Références
Nat Biotechnol. 2013 Sep;31(9):839-43
pubmed: 23934178
Microb Biotechnol. 2019 Nov;12(6):1293-1301
pubmed: 31055883
Science. 2010 Jan 8;327(5962):167-70
pubmed: 20056882
ACS Synth Biol. 2015 May 15;4(5):585-94
pubmed: 25207793
Metab Eng. 2015 Mar;28:213-222
pubmed: 25638686
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Appl Environ Microbiol. 2005 Oct;71(10):5743-51
pubmed: 16204483
Nucleic Acids Res. 2013 Apr;41(7):4336-43
pubmed: 23460208
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548